Bullish indication on daily chart

Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 26,110.00 |
| High | 26,770.00 |
| Low | 25,800.00 |
| Prev Close | 26,105.00 |
| Volume | 9,513 |
| VWAP(₹) | 26,379.38 |
| PE Ratio(x) | 36.22 |
| EPS - TTM(₹) | 730.39 |
| MCap(₹ Cr.) | 56,215.03 |
| MCap Rank | 14 |
| PB Ratio(x) | 11.62 |
| Div Yield(%) | 2.48 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 37,000.00 |
| 52W Low(₹) | 25,150.00 |
| MCap/Sales | 7.95 |
| Beta(1 Month) | 0.58 |
| BV/Share(₹) | 2,246.75 |
Dividend Announcement
Company announced a dividend of Rs 525.0 per share on May 11, 2026 with record date of Jul 24, 2026.Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.65% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Abbott India Share Price Update
Abbott India Ltd. share price moved up by 1.35% from its previous close of Rs 26,105.00. Abbott India Ltd. stock last traded price is 26,455.00
| Share Price | Value |
|---|---|
| Today/Current/Last | 26,455.00 |
| Previous Day | 26,105.00 |
Found Insights useful?
| 1 Day | 1.35% |
| 1 Month | -0.92% |
| 3 Months | -1.32% |
| 1 Year | -16.4% |
| 3 Years | 21.4% |
| 5 Years | 64.25% |
7 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 7 | 7 | 7 | 7 |
Announcement under Regulation 30 (LODR)-Newspaper Publication
AnnouncementsAnnouncement under Regulation 30 (LODR)-Newspaper Publication
Announcements| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 1,785.10 | 1,793.80 | 1,827.10 | 1,811.19 | 1,680.61 |
| Total Income Growth (%) | -0.49 | -1.82 | 0.88 | 7.77 | -0.32 |
| Total Expenses | 1,247.73 | 1,279.34 | 1,273.62 | 1,312.24 | 1,193.98 |
| Total Expenses Growth (%) | -2.47 | 0.45 | -2.94 | 9.90 | -0.18 |
| EBIT | 537.37 | 514.46 | 553.48 | 498.95 | 486.63 |
| EBIT Growth (%) | 4.45 | -7.05 | 10.93 | 2.53 | -0.66 |
| Profit after Tax (PAT) | 394.93 | 375.96 | 415.27 | 365.86 | 367.04 |
| PAT Growth (%) | 5.05 | -9.47 | 13.51 | -0.32 | 1.74 |
| EBIT Margin (%) | 30.10 | 28.68 | 30.29 | 27.55 | 28.96 |
| Net Profit Margin (%) | 22.12 | 20.96 | 22.73 | 20.20 | 21.84 |
| Basic EPS (₹) | 185.85 | 176.92 | 195.42 | 172.17 | 172.72 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.65% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 6,501.93 | 5,917.31 | 5,193.49 | 4,555.51 | 4,224.12 |
| Total Assets Growth (%) | 9.88 | 13.94 | 14.00 | 7.85 | 9.99 |
| Total Liabilities | 1,727.74 | 1,684.16 | 1,494.60 | 1,366.97 | 1,404.33 |
| Total Liabilities Growth (%) | 2.59 | 12.68 | 9.34 | -2.66 | 13.41 |
| Total Equity | 4,774.19 | 4,233.15 | 3,698.89 | 3,188.54 | 2,819.79 |
| Total Equity Growth (%) | 12.78 | 14.44 | 16.01 | 13.08 | 8.36 |
| Current Ratio (x) | 2.55 | 3.39 | 2.42 | 2.51 | 3.20 |
| Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Contingent Liabilities | 0.00 | 116.09 | 106.52 | 106.06 | 123.78 |
All figures in Rs Cr, unless mentioned otherwise
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 1,319.24 | 1,011.84 | 1,212.81 | 893.39 | 947.66 |
| Net Cash used in Investing Activities | -371.38 | 182.18 | -416.03 | -147.71 | -395.84 |
| Net Cash flow from Financing Activities | -1,066.12 | -925.17 | -744.71 | -638.72 | -637.38 |
| Net Cash Flow | -118.26 | 268.85 | 52.07 | 106.96 | -85.56 |
| Closing Cash & Cash Equivalent | 442.33 | 560.59 | 291.74 | 239.67 | 132.71 |
| Closing Cash & Cash Equivalent Growth (%) | -21.10 | 92.15 | 21.73 | 80.60 | -39.20 |
| Total Debt/ CFO (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 32.50 | 33.41 | 32.47 | 29.77 | 28.32 |
| Return on Capital Employed (%) | 41.87 | 42.09 | 42.33 | 38.50 | 36.37 |
| Return on Assets (%) | 23.87 | 23.90 | 23.12 | 20.84 | 18.90 |
| Interest Coverage Ratio (x) | 87.24 | 172.37 | 136.66 | 85.04 | 60.99 |
| Asset Turnover Ratio (x) | 1.12 | 1.15 | 1.20 | 1.22 | 1.22 |
| Price to Earnings (x) | 35.59 | 46.30 | 47.85 | 49.50 | 47.17 |
| Price to Book (x) | 11.54 | 15.43 | 15.48 | 14.72 | 13.34 |
| EV/EBITDA (x) | 24.23 | 32.32 | 32.40 | 33.09 | 29.93 |
| EBITDA Margin (%) | 31.46 | 30.74 | 29.08 | 25.42 | 23.68 |
Found Financials useful?
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
26305.00
LTP
26455.00
Choose from Peers
Choose from Stocks
Found Peer Comparison useful?
MF Ownership as on 30 April 2026
783.40
Amount Invested (in Cr.)
2.0387378%
% of AUM
12.05
% Change (MoM basis)
414.20
Amount Invested (in Cr.)
1.2833%
% of AUM
0.00
% Change (MoM basis)
352.51
Amount Invested (in Cr.)
1.43%
% of AUM
-0.16
% Change (MoM basis)
General Meeting
-
May 13, 2026
Special
1310%
May 12, 2026
General Meeting
-
May 11, 2026
| Announced on | Meeting on |
| Apr 30, 2026 | May 11, 2026 |
| Audited Results & Final Dividend | |
| Feb 04, 2026 | Feb 12, 2026 |
| Quarterly Results | |
| Oct 29, 2025 | Nov 06, 2025 |
| Quarterly Results | |
| Aug 04, 2025 | Aug 12, 2025 |
| Quarterly Results | |
| May 07, 2025 | May 15, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| May 12, 2026 | Jul 24, 2026 | 1310% |
| May 11, 2026 | Jul 24, 2026 | 5250% |
| May 15, 2025 | Jul 25, 2025 | 4750% |
| May 09, 2024 | Jul 19, 2024 | 4100% |
| May 20, 2023 | Jul 21, 2023 | 1450% |
| Announced on | Ex-Date |
| Aug 10, 1998 | Aug 17, 1998 |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Jun 22, 1988 | - |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Feb 02, 1987 | - |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Jun 22, 1984 | - |
| Bonus Ratio: 3 share(s) for every 5 shares held | |
| Jun 22, 1979 | - |
| Bonus Ratio: 1 share(s) for every 3 shares held | |
No Data Available
| Announced on | Ex-Date |
| Feb 02, 1994 | - |
| Rights ratio: 1 share for every 10 held at a price of Rs 15.0 | |
| Announced on | Meeting on |
| May 13, 2026 | Jun 18, 2026 |
| - | |
| May 11, 2026 | Aug 13, 2026 |
| - | |
| Jan 14, 2026 | Feb 19, 2026 |
| - | |
| May 15, 2025 | Aug 13, 2025 |
| - | |
| May 09, 2024 | Aug 08, 2024 |
| - | |
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 56,215.03 Crore) operating in Pharmaceuticals sector.
Industry
Key Indices Listed On
Nifty 500, BSE 500, Nifty Pharma, Nifty MNC, BSE MidCap
Address
3, Corporate Park,Sion-Trombay Road,Mumbai, Maharashtra - 400071
Munir Shaikh
ChairmanKartik Rajendran
Managing DirectorAlison Davies
Non Executive DirectorAmbati Venu
Non Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.